Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
暂无分享,去创建一个
D. Ardissino | M. Plebani | S. Savonitto | C. Cavallini | P. Rubartelli | R. Violini | G. Steffenino | Z. Olivari | S. Battaglia | L. Niccoli | G. Arraiz
[1] W. Takahashi,et al. [High-sensitivity C-reactive protein]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.
[2] I. Porto,et al. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study. , 2005, European heart journal.
[3] J. Svendsen,et al. Inflammation in the genesis and perpetuation of atrial fibrillation. , 2005, European heart journal.
[4] D. Kremastinos,et al. Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. , 2005, The American journal of cardiology.
[5] S. Petersen,et al. Troponin Elevation After Percutaneous Coronary Intervention Directly Represents the Extent of Irreversible Myocardial Injury: Insights From Cardiovascular Magnetic Resonance Imaging , 2005, Circulation.
[6] F. Apple,et al. Cardiac troponin and creatine kinase MB monitoring during in-hospital myocardial reinfarction. , 2005, Clinical chemistry.
[7] David O. Martin,et al. C-Reactive protein level and recurrence of atrial fibrillation after electrical cardioversion , 2005 .
[8] I. Kubota,et al. C-Reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation , 2005, Heart and Vessels.
[9] M. Roea,et al. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes , 2004 .
[10] Samin K. Sharma,et al. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. , 2004, The American journal of cardiology.
[11] B. Nallamothu,et al. Periprocedural myocardial infarction and mortality: causality versus association. , 2003, Journal of the American College of Cardiology.
[12] J. Ioannidis,et al. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. , 2003, Journal of the American College of Cardiology.
[13] J. Ioannidis,et al. Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions. , 2003, Journal of the American College of Cardiology.
[14] P. Serruys,et al. Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention , 2002 .
[15] E. Topol,et al. Death Following Creatine Kinase-MB Elevation After Coronary Intervention: Identification of an Early Risk Period: Importance of Creatine Kinase-MB Level, Completeness of Revascularization, Ventricular Function, and Probable Benefit of Statin Therapy , 2002, Circulation.
[16] V. Hasselblad,et al. Prognostic significance of elevated troponin I after percutaneous coronary intervention. , 2002, Journal of the American College of Cardiology.
[17] E. Topol,et al. Frequency and long-term impact of myonecrosis after coronary stenting. , 2002, European heart journal.
[18] M. Leon,et al. Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts , 2002, Circulation.
[19] M. Simoons,et al. Minor Myocardial Damage and Prognosis: Are Spontaneous and Percutaneous Coronary Intervention–Related Events Different? , 2002, Circulation.
[20] Deepak L. Bhatt,et al. Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes , 2001, Circulation.
[21] G. Stone,et al. Differential Impact on Survival of Electrocardiographic Q-Wave Versus Enzymatic Myocardial Infarction After Percutaneous Intervention: A Device-Specific Analysis of 7147 Patients , 2001, Circulation.
[22] R. Kim,et al. Visualization of Discrete Microinfarction After Percutaneous Coronary Intervention Associated With Mild Creatine Kinase-MB Elevation , 2001, Circulation.
[23] A. Wu,et al. Quality Specifications for Cardiac Troponin Assays , 2001, Clinical chemistry and laboratory medicine.
[24] J S Alpert,et al. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, Journal of the American College of Cardiology.
[25] Hugo A. Katus,et al. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.
[26] G. Stone,et al. Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions. , 2000, The American journal of cardiology.
[27] E. Antman,et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. , 1999, Circulation.
[28] Samin K. Sharma,et al. Final results of the Balloon vs Optimal Atherectomy Trial (BOAT) , 1998, Circulation.
[29] R. Califf,et al. Myonecrosis after revascularization procedures. , 1998, Journal of the American College of Cardiology.
[30] R. Bonow,et al. Prognostic implication of creatine kinase elevation following elective coronary artery interventions. , 1997, JAMA.
[31] E. Topol,et al. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. , 1996, Circulation.
[32] V. Gökhan Cin,et al. The prognostic value of serum troponin T in unstable angina. , 1996, International journal of cardiology.